Scott & Selber Inc. Has $3.52 Million Stake in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Scott & Selber Inc. reduced its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 2.3% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 6,743 shares of the medical equipment provider’s stock after selling 160 shares during the period. Intuitive Surgical accounts for approximately 1.1% of Scott & Selber Inc.’s investment portfolio, making the stock its 28th biggest position. Scott & Selber Inc.’s holdings in Intuitive Surgical were worth $3,520,000 as of its most recent SEC filing.

A number of other institutional investors have also recently made changes to their positions in ISRG. Berbice Capital Management LLC bought a new position in Intuitive Surgical during the fourth quarter worth $26,000. BankPlus Trust Department bought a new position in shares of Intuitive Surgical in the 4th quarter worth about $28,000. Kohmann Bosshard Financial Services LLC bought a new position in shares of Intuitive Surgical in the 4th quarter worth about $31,000. MidAtlantic Capital Management Inc. acquired a new position in shares of Intuitive Surgical in the 3rd quarter valued at about $33,000. Finally, Decker Retirement Planning Inc. bought a new stake in shares of Intuitive Surgical during the 4th quarter valued at about $36,000. Institutional investors own 83.64% of the company’s stock.

Analyst Upgrades and Downgrades

A number of brokerages have weighed in on ISRG. CICC Research assumed coverage on Intuitive Surgical in a report on Monday, January 27th. They issued a “neutral” rating and a $550.00 target price for the company. Evercore ISI lifted their price objective on shares of Intuitive Surgical from $490.00 to $530.00 in a research note on Monday, January 27th. Citigroup increased their target price on shares of Intuitive Surgical from $640.00 to $711.00 and gave the stock a “buy” rating in a research note on Friday, January 24th. UBS Group lifted their price target on shares of Intuitive Surgical from $500.00 to $560.00 and gave the company a “neutral” rating in a research note on Monday, January 27th. Finally, Piper Sandler reissued an “overweight” rating and set a $670.00 price objective (up previously from $538.00) on shares of Intuitive Surgical in a research report on Friday, January 24th. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and sixteen have given a buy rating to the stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $613.10.

Insider Buying and Selling

In related news, CFO Jamie Samath sold 270 shares of the stock in a transaction that occurred on Tuesday, December 10th. The stock was sold at an average price of $540.15, for a total transaction of $145,840.50. Following the completion of the sale, the chief financial officer now directly owns 8,757 shares of the company’s stock, valued at approximately $4,730,093.55. This trade represents a 2.99 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, SVP Mark Brosius sold 492 shares of the business’s stock in a transaction on Monday, March 3rd. The stock was sold at an average price of $573.78, for a total value of $282,299.76. Following the completion of the transaction, the senior vice president now directly owns 4,056 shares in the company, valued at approximately $2,327,251.68. This represents a 10.82 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 12,598 shares of company stock worth $7,223,467. 0.90% of the stock is owned by insiders.

Intuitive Surgical Price Performance

ISRG opened at $566.98 on Tuesday. Intuitive Surgical, Inc. has a 1 year low of $364.17 and a 1 year high of $616.00. The company has a market capitalization of $201.95 billion, a price-to-earnings ratio of 88.45, a P/E/G ratio of 5.85 and a beta of 1.39. The firm’s fifty day moving average price is $570.66 and its two-hundred day moving average price is $530.08.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.